BROCHURE: Comprehensive Single T Cell Profiling

Polyfunctionality and cytotoxicity with recovery of live T cells from an integrated platform.

POSTER: Multi-dimensional Single-cell Analysis of CD19-CAR T Cells Enable Unique Insights

POSTER: Discovery, Cloning and Functional Validation of a Neoantigen-specific Patient-derived TCR on the Berkeley Lights Platform

POSTER: A Rapid High-Throughput Workflow for TCR Discovery on Solid Tumors with Functional Verification

INFO SHEET: TechAccess Subscriptions

TechAccess Subscriptions provide access to Berkeley Lights’ revolutionary workflows no matter
the size of your lab, your customer base, or budget.

Webinar: Characterizing T Cell Functionality on the Berkeley Lights Lightning Platform

Hear from Dr. Anthony Zamora, Assistant Professor at Medical College of Wisconsin, discusses how the Lightning system enables rapid functional characterization of T cells and allows for thousands of single cells to be isolated, cultured, assayed, and exported for further analysis.

Poster: Multi-omic Analysis for Directly Linking T Cell Phenotype to Gene Expression

Find out how the OptoSeq™ Single Cell 3′ mRNA kit workflow enables automated, on-chip, bead-based capture of mRNA for reverse transcription to directly link phenotype to gene expression.

Webinar: Multi-omic Profiling of T Cells Using the OptoSeq™ Single Cell 3′ mRNA Library Kit

Watch this on-demand webinar from Dr. Jason McEwen, our Associate Director of Biology, as he walks you through how our OptoSeq™ Single Cell 3′ mRNA Library Kit will empower you to link differential gene expression data to single precious cells.

App Note: Perform Multi-omic Analysis to Directly Link T Cell Polyfunctionality to Gene Expression

Download this application note to learn about designing effective therapeutics by directly linking phenotype to gene expression using the OptoSeq™ Single Cell 3ʹ mRNA kit in the Opto™ Cell Therapy Development workflow.

Datasheet: The Opto™ Antigen Presenting Bead Kit

Learn more about the Opto™ Antigen Presenting Bead (Opto™ APB) Kit, its key applications, and how it benefits your cell therapy development workflows by efficiently expanding more antigen-specific T cells than dendritic cells.

Application Note: Unravel the Complexity of Single Natural Killer Cell Cytotoxicity and ADCC Mediation

Explore how the Cytotoxicity Assay can be used to characterize and better understand NK cells in the pursuit of more efficacious cell therapies.

BROCHURE: Cell Therapy Development

From expanding rare, antigen-specific T cells to fully characterizing them, learn how our capabilities are making cell therapy development more efficient.

Application Note: Multidimensional Analysis of T Cell Cytotoxicity and Serial Killing Using the Opto™ Cell Therapy Development Workflow

Learn how to use multiple assays on single T cells to finally understand critical functions, such as serial killing, and how they relate to each other.

Application Note: Identify and Select Optimal CAR T Cell Phenotypes with the Opto™ Cell Therapy Development Workflow

Learn how to combine the T Cell Proliferation Assay with either the Multiplex Cytokine Assay or Cytotoxicity Assay to find your most persistent T cells.

Webinar: Expand and Rapidly Validate Antigen-Specific Function of T Cells Using Fewer Cells

Yelena Bronevetsky, PhD, lays out the current challenges in tumor antigen discovery and how our Opto™ Antigen Presenting Bead Kit helps scientists overcome them.

Product Tour: The Opto™ Cell Therapy Development Workflow

Guided by T cell expert, Yelena Bronevetsky, PhD, get a deeper look at how the Opto™ Cell Therapy Development workflow can be used to validate, expand, and fully characterize over a 1,000 T cells.

Brochure: Lightning System

Find out how the Lightning platform lets you visualize diverse cell interactions, measure individual cell cytotoxicity, and recover cells of interest alive.

Webinar: How Pediatric Immune Systems Empower Cancer Immunotherapy

Dr. David Barrett shares insights into why children’s T cells help CAR-T cells succeed and discusses how the Opto Cell Therapy Development Workflow can provide the detailed characterization required to develop more efficacious therapies.